The Optispan Podcast with Matt Kaeberlein cover image

Does NMN Actually Increase VO2 MAX? | 61 - Longevity This Week #9

The Optispan Podcast with Matt Kaeberlein

00:00

Exploring NMN and its Regulatory Challenges

This chapter explores the potential health benefits of NMN as an NAD precursor and examines the regulatory hurdles it faces from the FDA. It also discusses the implications of these challenges on its availability in the market, particularly in relation to competition with pharmaceutical entities.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app